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Results: We were able to demonstrate the feasibility of our new 
acquisition technique for peak-inhale only, peak-exhale only, and mid-
ventilation only short (200°) and full scanning protocols. In the figure, 
a significant reduction in motion-related artefacts at the tumour 
surface is demonstrated. Reconstruction artefacts stemming from the 
presence of the EM-array were greatly reduced. Inherently, the 
method leads to a smooth distribution of projection angles over the 
entire gantry rotation. A typical CTDI imaging dose for a peak-exhale 
(360°, 375 fr., 5 min)/peak-inhale (200°, 106 fr., 2:47 min) protocol is 
~8/~2 mGy. 
 
  
Conclusions: We have implemented a new dose-saving 4D CBCT 
scanning protocol which reduces motion-artefacts by selecting the 
breathing phase(s) desired for reconstruction prior to image 
acquisition. We are currently implementing the acquisition of multiple 
phases in one gantry rotation. 
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Purpose/Objective: To develop and evaluate a tumour tracking 
method for the dynamic localization of extra-cranial targets during 
radiotherapy treatments, providing the continuous monitoring and 
compensation of intra-fraction organ motion due to breathing. The 
proposed approach is based on external surface surrogates estimated 
from non-invasive optical devices, and on patient-specific adaptive 
motion models derived from time-resolved planning and in-room X-ray 
imaging systems. 
Materials and Methods: A patient-specific motion model, 
parameterized as a function of the respiratory tumour baseline, 
amplitude and phase, is estimated from 4D CT planning images, by 
applying B-spline deformable registration between each 4D CT phase 
and the mid-position CT volume.The tumour baseline is adapted at 
each treatment fraction according to daily information on target 
localization derived from volumetric CBCT images. The breathing 
amplitude and phase parameters are retrieved from the external 
surface motion, acquired with 3D surface imaging systems. 
Deformable mesh registration is applied to derive the spatial 
correspondence between markerless optical surfaces. The obtained 3D 
trajectories of all thoraco-abdominal surface points are summarized 
into a single respiratory surrogate signal through k-means clustering 
techniques. The instantaneous values of the respiratory phase are 
extracted from the surface surrogate using the Hilbert transform. The 
amplitude scaling factor is obtained by comparing surface motion 
amplitudes during treatment planning and delivery. The adapted 
breathing parameters are integrated in the 4D CT motion model to 
estimate intra-fraction 3D tumor motion. 
Results: The developed tumour tracking method was tested on a 
clinical database of seven lung cancer patients, including the 
synchronized information on the external surface and internal tumour 
breathing motion during CBCT scans. About 30 seconds of 
synchronized acquisition of CBCT projections and optical surfaces, 
captured with the VisionRT system, were analyzed for each patient. 
The tumour trajectories estimated from surface displacement 
combined with the a priori 4D CT motion model were compared to the 
real target trajectories identified on CBCT images. The resulting 
absolute differences between real and estimated tumour motion 
ranged between 0.7 and 2.4 mm, with median values of 1.5 mm both 
along the horizontal and vertical image dimensions (Table 1). The 
measured phase shifts did not exceed the 7% of the breathing cycle 
length. 
 
  
Conclusions: The developed tumor tracking method proved to be 
effective in estimating tumour motion from the external surface 
displacement even in presence of breathing irregularities, as depicted 
in Figure 1. The innovative methodological aspects, related to the use 
of patient-specific adaptive motion models and to the redundancy of 
markerless surface data, are put forward to improve the accuracy and 
robustness of targeting techniques for intra-fraction organ motion 
compensation. 
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Purpose/Objective: In radiotherapy, fiducial markers are often 
implanted in the liver and used as x-ray visible surrogates for the 
tumour position. The basic assumption is that the tumour maintains a 
constant position relative to the marker throughout the treatment 
course. The aim of this study was to investigate the validity of this 
assumption by quantifying the geometric accuracy by which one 
implanted marker can predict the position of another marker in the 
liver.  
Materials and Methods: 26 patients with 2-3 implanted gold markers 
received stereotactic body radiation therapy to liver lesions in 3-6 
treatment fractions. At each fraction a cone-beam CT (CBCT) scan 
was acquired and used for marker based patient setup. After the 
treatments each marker was segmented in the projections of the 
CBCT scans, and the resulting 2D marker trajectories were used to 
estimate the 3D trajectory of each marker in patientspace by a 
probability based method. In total 198 3D marker trajectories with a 
mean duration of 51 seconds were recorded at 11 Hz over 90 
treatment fractions. The markers in the data set constituted 54 
marker pairs in total. For each marker pair, the error in estimating 
the 3D position of one marker from the 3D position of the other 
marker was calculated for each time point as the difference in the 3D 
shifts the two markers away from their respective mean positions. The 
root-mean-square (RMS) of this error was calculated for each marker 
pair as a measure for the intrafraction prediction error, during all 
fractions. Similarly, the interfraction RMS estimation error was 
calculated for each marker pair from the changes in the relative 3D 
mean marker positions from fraction to fraction.  
Results: The 3D position of an implanted marker was estimated from 
the position of another marker with a mean RMS error of 0.35 (LR), 
0.59 mm (CC), 0.47 mm (AP), and 0.86 +-0.57 mm (3D) intra-
fractionally, and of 0.52 mm (LR), 0.60 mm (CC), 0.59 mm (AP), and 
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1.1+-0.66 mm (3D) interfractionally. The 3D RMS estimation of error 
correlated significantly with the distance between the two markers 
(p<0.001), with an R2 of 0.59 for intrafraction errors, see Fig. 1. 
Different motion trajectories of the markers due to breathing, was the 
main cause of intrafraction errors. As the interfraction error estimate 
was based on average positions during CBCT acquisition, the effects of 
breathing were be less pronounced, and errors were most likely 
caused by drift of markers, liver deformations, and variations in 
patient rotation. 
Conclusions: We have quantified the intra- and inter-fraction 
prediction error of liver fiducial markers. In general, during 
treatment, the position of a marker could be predicted with a 3D RMS 
error below 1.5 mm from another surrogate marker when the distance 
between the markers were less than 5 cm. Between fractions, there 
was an average 3D RMS error of 1.1 +-0.66 mm. 
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Purpose/Objective: Radiotherapy for pancreatic tumors is currently 
limited by respiratory induced motion. Precise motion management is 
vital to ensure full dose coverage and limit toxicity in nearby organs 
at risk (OAR). MR-guidance opens up the way to visualize tumors and 
track OARs during treatment (Lagendijk, 2008). Volumetric (3D) MR-
imaging, however, is currently not fast enough to achieve the 
temporal resolution required for real-time beam steering. We 
therefore investigate two (fast) surrogate motion markers for 
pancreatic motion to be used in conjunction with (slower) 3D MRI. 
External monitoring by means of a respiratory pressure belt, is 
compared to internal tracking based on the motion of the diaphragm. 
Materials and Methods: 2D radial cine MR scans (bSSFP; TE/TR = 
1.29ms/2.6 ms) were acquired in six healthy subjects during free-
breathing (2m50s, 3 frames/sec). Scan planes were angulated parallel 
to the principal axis of motion. Simultaneously, the breathing signal 
was recorded using a respiratory pressure belt (surrogate 1). 1D MR 
navigators were simulated by tracking the cranial-caudal (CC) 
diaphragm motion on the 2D scans. 
Image analysis: Pancreatic motion is estimated on MR images, as 
reference data, using the optical flow algorithm, which has been 
successfully applied and validated for HIFU treatments (Roujol, 2011). 
The diaphragm motion (surrogate 2) was assessed separate from the 
pancreas motion. Power spectrum analysis were used to give insight in 
the CC motion frequencies. To assess the agreement of the surrogate 
motion markers and pancreatic motion, a general linear model (GLM) 
was calculated using Y = βX + ε , in which Y is the pancreatic motion, 
β the parameter estimate, X the surrogate motion signal (diaphragm 
or belt), and ε represents the residual error. Z-statistics are 
calculated to determine the model conformity. 
Results: All power spectra show peaks at the principle respiratory 
frequency (Fig 1a). However, significant low frequent components can 
be seen in the power spectra of the 2D cine-MRI and the navigator, 
whereas the respiratory belt shows only one small peak. Visual 
inspection of the data showed a global rigid body movement of the 
subject, which can not be detected by the belt. Both models showed 
good z-statistics for the pancreas. However, the residual error in the 
pancreas is much lower for the diaphragm surrogate (Fig. 1b and c). 
This implies that the diaphragm moves rigidly in a CC direction with 
the liver and pancreas and is thus a better predictor for motion than 
the respiratory belt. As expected, both models showed high residual 
error for through-plane motion (e.g. intestines). 
Conclusions: This data shows that diaphragm tracking (which can be 
accomplished with fast 1D MR navigators) is a better surrogate for 
pancreatic motion than external monitoring using a respiratory 
pressure belt. Furthermore, left-right motion can be characterized 
(results not shown) using internal tracking, which is not possible using 
external monitoring. Therefore, external monitoring should be used 
with care in motion characterization and prediction models. 
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Purpose/Objective: We have applied infrared (IR)-marker-based 
dynamic tumour tracking irradiation (IR tracking) with Vero4DRT (MHI-
TM2000) clinically to lung cancer patients since September 2011. This 
study quantified the accuracy of the predictive model of IR tracking 
for lung cancer using log files. 
Materials and Methods: Before beam delivery, a predictive model (4D 
model), which correlates the displacement of IR markers on the 
abdomen with the three-dimensional (3D) position of a tumour 
indicated by implanted gold markers, is required. The IR and gold 
markers were monitored for 40 s with the IR camera every 16.7 ms 
and an orthogonal kV X-ray imaging subsystem every 80 or 160 ms, 
respectively. The 4D model predicted the future target position from 
the displacement of the IR markers in real-time, and the gimbaled x-
ray head then tracked the moving tumour continuously, based on the 
predicted target position. In clinical practice, we updated the 4D 
model at least once during each treatment session to ensure 
predictive accuracy. 
This study evaluated the 4D modelling error (E4DM) and influence of the 
intrafractional baseline drift of the IR marker position on the 
predicted target position (EIR). E4DM was defined as the difference 
between the predicted and detected target positions during the 
modelling duration and EIR was defined as the difference between the 
predicted target positions generated from parameters of previous and 
updated 4D model. For E4DM and EIR, the overall mean (M), systematic 
(Σ), and random (σ) errors were calculated from the log files of ten 
patients who underwent IR tracking. A total of 112 and 55 log files 
were analyzed for the E4DM and EIR, respectively. 
Results: The respiratory motion amplitudes of the lung tumours 
ranged from 1.0–7.5, 4.7–28.5, and 2.4–10.5 mm in the left-right (LR), 
cranio-caudal (CC), and anterior-posterior (AP) directions, 
respectively. For the E4DM, (M, Σ, σ) (in mm) were (0.0, 0.0, 0.4), (0.0, 
0.0, 0.8), and (0.0, 0.0, 0.6) in the LR, CC, and AP directions, 
respectively. The local maximum E4DM commonly appeared around the 
peak of the respiratory pattern (Fig. 1). The median time elapsed 
until the 4D model was updated was 13 (range 2–23) min. For the EIR, 
(M, Σ, σ) (in mm) were (0.0, 0.3, 0.2), (0.2, 0.9, 0.5), and (0.4, 0.6, 
0.3) in the LR, CC, and AP directions, respectively. If the 4D model 
was not updated in the presence of intrafractional baseline drift, the 
predicted target position deviated from the detected target position 
systematically (Fig. 1). 
